Cargando…

The heart in transfusion dependent homozygous thalassaemia today – prediction, prevention and management

Cardiac disease remains the major cause of death in thalassaemia major. This review deals with the mechanisms involved in heart failure development, the peculiar clinical presentation of congestive heart failure and provides guidelines for diagnosis and management of the acute phase of cardiac failu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aessopos, Athanassios, Berdoukas, Vasilios, Tsironi, Maria
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2253710/ https://www.ncbi.nlm.nih.gov/pubmed/18081719 http://dx.doi.org/10.1111/j.1600-0609.2007.01018.x

Ejemplares similares

Prevention of Cardiomyopathy in Transfusion-Dependent Homozygous Thalassaemia Today and the Role of Cardiac Magnetic Resonance Imaging
por: Aessopos, Athanassios, et al.
Publicado: (2009)

Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance (CMR) imaging in transfusion dependent thalassemia major (TM)
por: Giakoumis, Anastasios, et al.
Publicado: (2007)

Cardiac Function and Iron Chelation in Thalassemia Major and Intermedia: a Review of the Underlying Pathophysiology and Approach to Chelation Management
por: Aessopos, Athanasios, et al.
Publicado: (2009)

Experiences, Knowledge Gaps and Information Needs of Women in Australia with Transfusion Dependent Thalassaemia in Regard to Fertility and Pregnancy
por: Matthiesson, Hannah K, et al.
Publicado: (2023)

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Status of Superoxide Dismutase in Transfusion Dependent Thalassaemia
por: Rujito, Lantip, et al.
Publicado: (2015)

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia
por: Gavriilaki, Eleni, et al.
Publicado: (2018)

When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia
por: Taher, A T, et al.
Publicado: (2015)

The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study
por: Berdoukas, Vasilios, et al.
Publicado: (2009)

A Java-based Electronic Healthcare Record Software for Beta-thalassaemia
por: Deftereos, S, et al.
Publicado: (2001)

Factors affecting height in children and adolescents with transfusion-dependent Thalassaemia – results from a Thalassaemia center in Malaysia
por: Ting, Tzer Hwu, et al.
Publicado: (2013)

Iron overload across the spectrum of non‐transfusion‐dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
por: Porter, John B., et al.
Publicado: (2016)

Rapid iron loading in a pregnant woman with transfusion-dependent thalassemia after brief cessation of iron chelation therapy
por: Farmaki, Kallistheni, et al.
Publicado: (2008)

Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients
por: Ahmed, Azza Mohamed, et al.
Publicado: (2010)

Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit
por: Ladis, Vassilios, et al.
Publicado: (2010)

Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective
por: Shafie, Asrul Akmal, et al.
Publicado: (2021)

Psychiatric disorders and caregiver burden in children with transfusion dependent β-thalassaemia and their caregivers
por: Sahu, Samiksha, et al.
Publicado: (2023)

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019)

Psychological morbidity among children with transfusion dependent β-thalassaemia and their parents in Sri Lanka
por: Mettananda, Sachith, et al.
Publicado: (2020)

Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
por: Subahi, Eihab A., et al.
Publicado: (2022)

Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition
por: Viprakasit, Vip, et al.
Publicado: (2014)

Successful Management of Severe Hyperhaemolysis with Combined Tocilizumab and Rituximab in Non-Transfusion-Dependent Thalassaemia: A Case Report
por: El Afifi, Amal M., et al.
Publicado: (2022)

Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia
por: Taher, Ali T, et al.
Publicado: (2023)

Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study
por: Mettananda, Sachith, et al.
Publicado: (2019)

Increased Microerythrocyte Count in Homozygous α(+)-Thalassaemia Contributes to Protection against Severe Malarial Anaemia
por: Fowkes, Freya J. I, et al.
Publicado: (2008)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia
por: Yasara, Nirmani, et al.
Publicado: (2022)

Quality of life and challenges experienced by the surviving adults with transfusion dependent thalassaemia in Malaysia: a cross sectional study
por: Foong, Wai Cheng, et al.
Publicado: (2022)

Epidemiology of Transfusion Transmitted Infection among Patients with β-Thalassaemia Major in Pakistan
por: Ahmed Kiani, Rizwan, et al.
Publicado: (2016)

Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial
por: Yasara, Nirmani, et al.
Publicado: (2020)

Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study
por: Medina, Katia Menacho, et al.
Publicado: (2021)

Transfusion-induced Plasmodium falciparum malaria in a beta thalassaemia patient during the prevention of re-establishment phase in Sri Lanka
por: Chulasiri, Pubudu, et al.
Publicado: (2021)

α-thalassaemia
por: Harteveld, Cornelis L, et al.
Publicado: (2010)

Thalassaemia Intermedia: an Update
por: Taher, Ali T., et al.
Publicado: (2009)

Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control
por: Suriapperuma, Tharindi, et al.
Publicado: (2018)

Routine management, healthcare resource use and patient and carer‐reported outcomes of patients with transfusion‐dependent β‐thalassaemia in the United Kingdom: A mixed methods observational study
por: Shah, Farrukh, et al.
Publicado: (2021)

Screening for beta thalassaemia
por: Petrou, Mary
Publicado: (2010)

Transfusion-Related Acute Lung Injury (TRALI) in two Thalassaemia Patients Caused by the Same Multiparous Blood Donor
por: Kolnagou, Annita, et al.
Publicado: (2017)

Thalassaemia and Aberrations of Growth and Puberty
por: Kyriakou, Andreas, et al.
Publicado: (2009)

THALASSAEMIA IS A TROPICAL DISEASE
por: Kotila, T.R.
Publicado: (2012)

Red cell alloantibodies in beta-thalassaemia major patients’ blood referring to the regional blood transfusion center of Tehran, Iran
por: Ebrahimisadr, Parisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3npsa5i1mlmh2c85n4cbk245ii